Lantheus Holdings, Inc. (LNTH) vs Regencell Bioscience Holdings Limited (RGC)
- Lantheus Holdings, Inc. LNTH 99.70 −0.29%
- Regencell Bioscience Holdings Limited RGC 9.59 +0.74%
Lantheus Holdings, Inc. and Regencell Bioscience Holdings Limited are both Drug Manufacturers Specialty & Generic companies. Lantheus Holdings, Inc. is the larger, with a market value of $6.5B against $4.7B — 1.4× the size. Regencell Bioscience Holdings Limited has negative trailing earnings, so its P/E is not meaningful; Lantheus Holdings, Inc. trades at 23.7×. Lantheus Holdings, Inc. has the higher net margin (17.7% vs 0.00%) and the higher return on invested capital (14.7% vs 0.00%). Across the 12 metrics below, Lantheus Holdings, Inc. leads on 10 and Regencell Bioscience Holdings Limited on 2.
Valuation
Profitability
| Metric | LNTH | RGC | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 60.14% | — | 53.94% |
| Operating margin | 19.43% | — | 0.00% |
| Net margin | 17.69% | 0.00% | 0.00% |
| Free cash flow margin | 25.24% | 0.00% | 0.00% |
| Return on equity | 22.21% | 0.00% | (0.40%) |
| Return on assets | 12.15% | 0.00% | (3.32%) |
| Return on invested capital | 14.65% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack